Research graph
References from Cancer incidence and risk factors among people with HIV in REPRIEVE. Local targets link to admitted publications; unresolved targets remain external evidence.
HIV-1, HAART and cancer: a complex relationship
10.1002/ijc.32730 · 2020 · External reference
The role of viruses in cancer development versus cancer therapy: an oncological perspective
10.1002/cam4.5694 · 2023 · External reference
Incidence and mortality of non-AIDS-defining cancers among people living with HIV: a systematic review and meta-analysis
10.1016/j.eclinm.2022.101613 · 2022 · External reference
Elevated cancer-specific mortality among HIV-infected patients in the United States
10.1200/jco.2014.59.5967 · 2015 · External reference
Cancer incidence and trends in US adults with HIV
10.1001/jamaoncol.2025.1589 · 2025 · External reference
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
10.1016/s0140-6736(14)60604-8 · 2014 · External reference
Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy
10.1002/cncr.20354 · 2004 · External reference
Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base
10.1002/cncr.32158 · 2019 · External reference
The effect of non-AIDS-defining cancers on people living with HIV
10.1016/s1470-2045(21)00137-6 · 2021 · External reference
Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the United States through 2030
10.7326/m17-2499 · 2018 · External reference
Cancer burden in the HIV-infected population in the United States
10.1093/jnci/djr076 · 2011 · External reference
Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy
10.1093/cid/cit369 · 2013 · External reference
Age and cancer incidence in 5.2 million people with human immunodeficiency virus (HIV): the South African HIV Cancer Match Study
10.1093/cid/ciac925 · 2023 · External reference
Comparison of Kaposi sarcoma risk in human immunodeficiency virus-positive adults across 5 continents: a multiregional multicohort study
10.1093/cid/cix480 · 2017 · External reference
Cervical cancer risk in women living with HIV across four continents: a multicohort study
10.1002/ijc.32260 · 2020 · External reference
Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort
10.1097/qad.0000000000000382 · 2014 · External reference
Time trends in cancer incidence in Australian people living with HIV between 1982 and 2012
10.1111/hiv.13179 · 2022 · External reference
Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study
10.1016/s2352-3018(17)30125-x · 2017 · External reference
The trends and risk factors of AIDS-defining cancers and non-AIDS-defining cancers in adults living with and without HIV: a narrative review
2024 · External reference
Cancer in people with HIV
10.1016/j.idc.2024.06.007 · 2024 · External reference
Cancer and HIV: the molecular mechanisms of the deadly duo
10.3390/cancers16030546 · 2024 · External reference
Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies
10.1016/s2352-3018(18)30295-9 · 2019 · External reference
Lung cancer mortality associated with smoking and smoking cessation among people living with HIV in the United States
10.1001/jamainternmed.2017.4349 · 2017 · External reference
Cancer burden attributable to cigarette smoking among HIV-infected people in North America
10.1097/qad.0000000000001721 · 2018 · External reference
Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals
10.1097/qad.0000000000001434 · 2017 · External reference
Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGE(h)IV cohort study
10.1016/s2352-3018(22)00400-3 · 2023 · External reference
State of the science and future directions for research on HIV and cancer: summary of a joint workshop sponsored by IARC and NCI
10.1002/ijc.34727 · 2024 · External reference
Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohort
10.1093/cid/ciaf248 · 2025 · External reference
Oncogenic effects of HIV-1 proteins, mechanisms behind
10.3390/cancers13020305 · 2021 · External reference
Combination antiretroviral therapy and cancer risk
10.1097/coh.0000000000000334 · 2017 · External reference
Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons
10.1097/qad.0b013e32835935b3 · 2012 · External reference
Statin effects on the incidence of major noncardiovascular disease events among a global cohort of people with HIV: a randomised controlled trial
10.1016/s2352-3018(24)00345-x · 2025 · External reference
Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence
10.1038/nrc.2017.68 · 2017 · External reference
Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)
10.1016/j.ahj.2018.12.016 · 2019 · External reference
Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk
10.1097/coh.0000000000000025 · 2014 · External reference
CD4/CD8 ratio and cancer risk among adults with HIV
10.1093/jnci/djac053 · 2022 · External reference
Cancer risk factors among people living with HIV/AIDS in China: a systematic review and meta-analysis
10.1038/s41598-017-05138-x · 2017 · External reference
Cancer burden and risk factors among women with HIV: a multiregional study from the D:A:D and RESPOND cohort collaborations
10.1016/j.eclinm.2025.103739 · 2026 · External reference
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies
10.1016/s0140-6736(03)15268-3 · 2004 · External reference
Report of a WHO consultation
2000 · External reference
Cold and hot tumors: from molecular mechanisms to targeted therapy
10.1038/s41392-024-01979-x · 2024 · External reference
Hot and cold tumors: immunological features and the therapeutic strategies
10.1002/mco2.343 · External reference
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
10.1186/s40425-018-0479-7 · 2018 · External reference
Flexible regression models with cubic splines
10.1002/sim.4780080504 · 1989 · External reference
The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide
10.1002/ijc.35278 · 2025 · External reference
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 · External reference
Global burden of cancer attributable to HIV: a worldwide incidence analysis
10.1016/s2214-109x(25)00264-5 · 2025 · External reference
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
10.1016/s2214-109x(19)30488-7 · 2020 · External reference
Evolving epidemiology of HIV-associated malignancies
10.1097/coh.0000000000000327 · 2017 · External reference
Assessing the impact of HAART on the incidence of defining and nondefining AIDS cancers among patients with HIV/AIDS: a systematic review
10.1016/j.jiph.2014.08.003 · 2015 · External reference
Profiling global cancer incidence and mortality by socioeconomic development
10.1002/ijc.33114 · 2020 · External reference
Patients with HIV-associated cancers have evidence of increased T cell dysfunction and exhaustion prior to cancer diagnosis
10.1136/jitc-2022-004564 · 2022 · External reference
Non-Hodgkin lymphoma risk in adults living with HIV across five continents
10.1097/qad.0000000000002003 · 2018 · External reference
The burden of cancers associated with HIV in the South African public health sector, 2004–2014: a record linkage study
10.1186/s13027-019-0228-7 · 2019 · External reference
Cancer incidence following expansion of HIV treatment in Botswana
10.1371/journal.pone.0135602 · 2015 · External reference
Elimination of cervical cancer in Tanzania: modelled analysis of elimination in the context of endemic HIV infection and active HIV control
10.1002/ijc.33533 · 2021 · External reference
Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: a mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence
10.1016/j.eclinm.2022.101306 · 2022 · External reference
HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer
10.1097/qad.0000000000001765 · 2018 · External reference
Estimates of the global burden of cervical cancer associated with HIV
10.1016/s2214-109x(20)30459-9 · 2021 · External reference
Sex disparities in the incidence of 21 cancer types: quantification of the contribution of risk factors
10.1002/cncr.34390 · 2022 · External reference
HIV infection, aging, and immune function: implications for cancer risk and prevention
10.1097/cco.0b013e328355e131 · 2012 · External reference
National estimates of prevalence, time-trend, and correlates of smoking in US people living with HIV (NHANES 1999–2016)
10.1093/ntr/ntaa277 · 2021 · External reference
Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys
10.7326/m14-0954 · 2015 · External reference
Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries
10.1016/s2214-109x(17)30170-5 · 2017 · External reference
Cancer prevention in HIV-infected populations
10.1053/j.seminoncol.2015.09.011 · 2016 · External reference
The association of HIV control and immunosuppression with risk of non-AIDS-defining cancer risk among patients on antiretroviral therapy
10.1097/qai.0000000000003350 · 2024 · External reference
Associations of CD4 cell count measures with infection-related and infection-unrelated cancer risk among people with HIV
10.1097/qai.0000000000003452 · 2024 · External reference
Failure to restore CD4+ cell count associated with infection-related and noninfection-related cancer
10.1097/qad.0000000000003117 · 2022 · External reference
HIV infection is associated with an increased risk for lung cancer, independent of smoking
10.1086/518606 · 2007 · External reference
Immune deficiency and risk for malignancy among persons with AIDS
10.1097/00126334-200304150-00010 · 2003 · External reference
Association of cancer with AIDS-related immunosuppression in adults
10.1001/jama.285.13.1736 · 2001 · External reference
Predicting Risk of Cardiovascular Disease Events (PREVENT) score accuracy among people with HIV in the multicenter CNICS cohort
10.1097/qad.0000000000004331 · 2025 · External reference
Prediction of cardiovascular risk among people with HIV using the PREVENT equations compared to the pooled cohort equations
10.1007/s11606-025-09642-z · 2026 · External reference
Association of cancer with AIDS-related immunosuppression in adults
10.1001/jama.285.13.1736 · ExternalCitation · doi-reference
Lung cancer mortality associated with smoking and smoking cessation among people living with HIV in the United States
10.1001/jamainternmed.2017.4349 · ExternalCitation · doi-reference
Cancer incidence and trends in US adults with HIV
10.1001/jamaoncol.2025.1589 · ExternalCitation · doi-reference
The role of viruses in cancer development versus cancer therapy: an oncological perspective
10.1002/cam4.5694 · ExternalCitation · doi-reference
Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy
10.1002/cncr.20354 · ExternalCitation · doi-reference
Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base
10.1002/cncr.32158 · ExternalCitation · doi-reference
Sex disparities in the incidence of 21 cancer types: quantification of the contribution of risk factors
10.1002/cncr.34390 · ExternalCitation · doi-reference
Cervical cancer risk in women living with HIV across four continents: a multicohort study
10.1002/ijc.32260 · ExternalCitation · doi-reference
HIV-1, HAART and cancer: a complex relationship
10.1002/ijc.32730 · ExternalCitation · doi-reference
Profiling global cancer incidence and mortality by socioeconomic development
10.1002/ijc.33114 · ExternalCitation · doi-reference
Elimination of cervical cancer in Tanzania: modelled analysis of elimination in the context of endemic HIV infection and active HIV control
10.1002/ijc.33533 · ExternalCitation · doi-reference
State of the science and future directions for research on HIV and cancer: summary of a joint workshop sponsored by IARC and NCI
10.1002/ijc.34727 · ExternalCitation · doi-reference
The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide
10.1002/ijc.35278 · ExternalCitation · doi-reference
Hot and cold tumors: immunological features and the therapeutic strategies
10.1002/mco2.343 · ExternalCitation · doi-reference
Flexible regression models with cubic splines
10.1002/sim.4780080504 · ExternalCitation · doi-reference
Prediction of cardiovascular risk among people with HIV using the PREVENT equations compared to the pooled cohort equations
10.1007/s11606-025-09642-z · ExternalCitation · doi-reference
Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)
10.1016/j.ahj.2018.12.016 · ExternalCitation · doi-reference
Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: a mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence
10.1016/j.eclinm.2022.101306 · ExternalCitation · doi-reference
Incidence and mortality of non-AIDS-defining cancers among people living with HIV: a systematic review and meta-analysis
10.1016/j.eclinm.2022.101613 · ExternalCitation · doi-reference
Cancer burden and risk factors among women with HIV: a multiregional study from the D:A:D and RESPOND cohort collaborations
10.1016/j.eclinm.2025.103739 · ExternalCitation · doi-reference
Cancer in people with HIV
10.1016/j.idc.2024.06.007 · ExternalCitation · doi-reference
Assessing the impact of HAART on the incidence of defining and nondefining AIDS cancers among patients with HIV/AIDS: a systematic review
10.1016/j.jiph.2014.08.003 · ExternalCitation · doi-reference
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies
10.1016/s0140-6736(03)15268-3 · ExternalCitation · doi-reference
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
10.1016/s0140-6736(14)60604-8 · ExternalCitation · doi-reference
The effect of non-AIDS-defining cancers on people living with HIV
10.1016/s1470-2045(21)00137-6 · ExternalCitation · doi-reference
Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries
10.1016/s2214-109x(17)30170-5 · ExternalCitation · doi-reference
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
10.1016/s2214-109x(19)30488-7 · ExternalCitation · doi-reference
Estimates of the global burden of cervical cancer associated with HIV
10.1016/s2214-109x(20)30459-9 · ExternalCitation · doi-reference
Global burden of cancer attributable to HIV: a worldwide incidence analysis
10.1016/s2214-109x(25)00264-5 · ExternalCitation · doi-reference
Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study
10.1016/s2352-3018(17)30125-x · ExternalCitation · doi-reference
Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies
10.1016/s2352-3018(18)30295-9 · ExternalCitation · doi-reference
Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGE(h)IV cohort study
10.1016/s2352-3018(22)00400-3 · ExternalCitation · doi-reference
Statin effects on the incidence of major noncardiovascular disease events among a global cohort of people with HIV: a randomised controlled trial
10.1016/s2352-3018(24)00345-x · ExternalCitation · doi-reference
Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence
10.1038/nrc.2017.68 · ExternalCitation · doi-reference
Cold and hot tumors: from molecular mechanisms to targeted therapy
10.1038/s41392-024-01979-x · ExternalCitation · doi-reference
Cancer risk factors among people living with HIV/AIDS in China: a systematic review and meta-analysis
10.1038/s41598-017-05138-x · ExternalCitation · doi-reference
Cancer prevention in HIV-infected populations
10.1053/j.seminoncol.2015.09.011 · ExternalCitation · doi-reference
HIV infection is associated with an increased risk for lung cancer, independent of smoking
10.1086/518606 · ExternalCitation · doi-reference
Age and cancer incidence in 5.2 million people with human immunodeficiency virus (HIV): the South African HIV Cancer Match Study
10.1093/cid/ciac925 · ExternalCitation · doi-reference
Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohort
10.1093/cid/ciaf248 · ExternalCitation · doi-reference
Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy
10.1093/cid/cit369 · ExternalCitation · doi-reference
Comparison of Kaposi sarcoma risk in human immunodeficiency virus-positive adults across 5 continents: a multiregional multicohort study
10.1093/cid/cix480 · ExternalCitation · doi-reference
CD4/CD8 ratio and cancer risk among adults with HIV
10.1093/jnci/djac053 · ExternalCitation · doi-reference
Cancer burden in the HIV-infected population in the United States
10.1093/jnci/djr076 · ExternalCitation · doi-reference
National estimates of prevalence, time-trend, and correlates of smoking in US people living with HIV (NHANES 1999–2016)
10.1093/ntr/ntaa277 · ExternalCitation · doi-reference
Immune deficiency and risk for malignancy among persons with AIDS
10.1097/00126334-200304150-00010 · ExternalCitation · doi-reference
HIV infection, aging, and immune function: implications for cancer risk and prevention
10.1097/cco.0b013e328355e131 · ExternalCitation · doi-reference
Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk
10.1097/coh.0000000000000025 · ExternalCitation · doi-reference
Evolving epidemiology of HIV-associated malignancies
10.1097/coh.0000000000000327 · ExternalCitation · doi-reference
Combination antiretroviral therapy and cancer risk
10.1097/coh.0000000000000334 · ExternalCitation · doi-reference
Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort
10.1097/qad.0000000000000382 · ExternalCitation · doi-reference
Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals
10.1097/qad.0000000000001434 · ExternalCitation · doi-reference
Cancer burden attributable to cigarette smoking among HIV-infected people in North America
10.1097/qad.0000000000001721 · ExternalCitation · doi-reference
HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer
10.1097/qad.0000000000001765 · ExternalCitation · doi-reference
Non-Hodgkin lymphoma risk in adults living with HIV across five continents
10.1097/qad.0000000000002003 · ExternalCitation · doi-reference
Failure to restore CD4+ cell count associated with infection-related and noninfection-related cancer
10.1097/qad.0000000000003117 · ExternalCitation · doi-reference
Predicting Risk of Cardiovascular Disease Events (PREVENT) score accuracy among people with HIV in the multicenter CNICS cohort
10.1097/qad.0000000000004331 · ExternalCitation · doi-reference
Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons
10.1097/qad.0b013e32835935b3 · ExternalCitation · doi-reference
The association of HIV control and immunosuppression with risk of non-AIDS-defining cancer risk among patients on antiretroviral therapy
10.1097/qai.0000000000003350 · ExternalCitation · doi-reference
Associations of CD4 cell count measures with infection-related and infection-unrelated cancer risk among people with HIV
10.1097/qai.0000000000003452 · ExternalCitation · doi-reference
Time trends in cancer incidence in Australian people living with HIV between 1982 and 2012
10.1111/hiv.13179 · ExternalCitation · doi-reference
Patients with HIV-associated cancers have evidence of increased T cell dysfunction and exhaustion prior to cancer diagnosis
10.1136/jitc-2022-004564 · ExternalCitation · doi-reference
The burden of cancers associated with HIV in the South African public health sector, 2004–2014: a record linkage study
10.1186/s13027-019-0228-7 · ExternalCitation · doi-reference
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
10.1186/s40425-018-0479-7 · ExternalCitation · doi-reference
Elevated cancer-specific mortality among HIV-infected patients in the United States
10.1200/jco.2014.59.5967 · ExternalCitation · doi-reference
Cancer incidence following expansion of HIV treatment in Botswana
10.1371/journal.pone.0135602 · ExternalCitation · doi-reference
Oncogenic effects of HIV-1 proteins, mechanisms behind
10.3390/cancers13020305 · ExternalCitation · doi-reference
Cancer and HIV: the molecular mechanisms of the deadly duo
10.3390/cancers16030546 · ExternalCitation · doi-reference
Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys
10.7326/m14-0954 · ExternalCitation · doi-reference
Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the United States through 2030
10.7326/m17-2499 · ExternalCitation · doi-reference